Market Overview

Benzinga’s Top Pre-Market NASDAQ Losers (IMGN, OVTI, NOVL, ARMH)


ImmunoGen Inc (NASDAQ: IMGN) dipped 23.12% to $6.45 in the pre-market session. IMGN has received a Refuse to File (RTF) letter from the FDA for its breast cancer treatment.

OmniVision Technologies Inc (NASDAQ: OVTI) lost 2.85% to $21.50 in the pre-market session. OVTI had reported weaker-than-expected Q1 revenue.

Novell Inc (NASDAQ: NOVL) fell 2.30% to $5.51 in the pre-market session. NOVL had posted weaker-than-expected FQ3 results.

ARM Holdings Plc (NASDAQ: ARMH) slipped 0.91% to $15.29 in pre-market trading. ARMH’s earnings are likely to fall by 8.26% this year.

Read more from Benzinga's Company news.


Related Articles (ARMH + IMGN)

View Comments and Join the Discussion!

Posted-In: Top Pre-Market NASDAQ LosersEarnings News FDA Pre-Market Outlook Intraday Update Markets Trading Ideas